Last Updated: December 16, 2021 Last Updated: December 16, 2021 Colchicine is an anti-inflammatory drug that is used to treat a variety of conditions, including gout, recurrent pericarditis, and familial Mediterranean fever.1 Recently, the drug has been shown to potentially reduce the risk of cardiovascular events in those with coronary artery disease.2 Colchicine has several potential mechanisms of action, […]
Authors: Deepalakshmi Kaliyaperumal,1Kumar Bhargavi,2Karthikeyan Ramaraju,3Krishna S Nair,4Sudha Ramalingam,5 and Murali Alagesan6 Indian J Crit Care Med. 2022 Jan; 26(1): 43–48.doi: 10.5005/jp-journals-10071-24045PMCID: PMC8783240PMID: 35110843 Abstract Background Coronavirus disease-2019 (COVID-19) infection is a multisystem disease not restricted to the lungs. It has a negative impact on the cardiovascular system by causing myocardial damage, vascular inflammation, plaque instability, and myocardial infarction. The presence […]
Authors: Saima May Sidik 10 February 2022 Massive study shows a long-term, substantial rise in risk of cardiovascular disease, including heart attack and stroke, after a SARS-CoV-2 infection. Even a mild case of COVID-19 can increase a person’s risk of cardiovascular problems for at least a year after diagnosis, a new study1 shows. Researchers found that […]
Authors: Yan Xie, Evan Xu, Benjamin Bowe & Ziyad Al-Aly Nature Medicine (2022) Abstract The cardiovascular complications of acute coronavirus disease 2019 (COVID-19) are well described, but the post-acute cardiovascular manifestations of COVID-19 have not yet been comprehensively characterized. Here we used national healthcare databases from the US Department of Veterans Affairs to build a cohort of 153,760 individuals with […]
Authors: Marcus Ståhlberg, MD, PhD,a,⁎ Ulrika Reistam, MD,a Artur Fedorowski, MD, PhD,b,c Humberto Villacorta, MD,d Yu Horiuchi, MD,e Jeroen Bax, MD,f Bertram Pitt, MD,g Simon Matskeplishvili, MD,h Thomas F. Lüscher, MD, PhD,i,j Immo Weichert, MD,k Khalid Bin Thani, MD,l and Alan Maisel, MDm Am J Med. 2021 Dec; 134(12): 1451–1456.Published online 2021 Aug. doi: 10.1016/j.amjmed.2021.07.004 Abstract In this paper we highlight the presence of tachycardia in post-acute COVID-19 syndrome by […]
